HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells

Human Gene Therapy

Volumn 8, Issue 3, 1997, Pages 359-370

  Johnston, Karen M ^a,b   Jacoby, David ^a   Pechan, Peter A ^a   Fraefel, Cornel ^a,c   Borghesani, Paul ^a,d   Schuback, Deborah ^a   Dunn, Robert J ^b   Smith, Frances I ^e   Breakefield, Xandra O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MCLEAN HOSPITAL   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; CELL DIVISION; CONTROLLED STUDY; DNA CLEAVAGE; DNA INTEGRATION; DNA PACKAGING; DNA REPLICATION ORIGIN; EPISOME; GENE AMPLIFICATION; GENE EXPRESSION; GLIOMA CELL; HELPER VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; REPORTER GENE; TOXICITY; TRANSGENE; VIRUS ASSEMBLY; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; HERPES; HUMAN HERPESVIRUS 1;

EID: 0030812867     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.3-359     Document Type: Article

References (52)

1. BERNS, K.I. (1996). Parvoviridae: The viruses and their replication. In Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia) pp. 2173-2197.
2. BOHENZKY, R.A., and BERNS, K.I. (1989). Interactions between the termini of adeno-associated virus DNA. J. Mol. Biol. 206, 91-100.
3. BOOTHMAN, D.A., GELLER, A.I., and PARDEE, A.B. (1989). Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells. FEBS Lett. 258, 159-162.
4. BREAKEFIELD, X.O., KRAMM, C.M., CHIOCCA, E.A., and PECHAN, P.A. (1995). Herpes simplex virus vectors for tumor therapy. In The Internet Book of Gene Therapy: Cancer Gene Therapeutics. R.E. Sobol and K.J. Scanlon, eds. (Appleton and Lange, Stamford, CT) pp. 41-56.
5. BROWNE, H., BELL, S., MINSON, T., and WILSON, D.W. (1996). An endoplasmic reticulum-retained herpes simplex virus glycoprotein H is absent from selected virions: Evidence for reenvelopment during egress. J. Virol. 70, 4311-4316.
6. CUNNINGHAM, C., and DAVISON, A.J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197, 116-124.
7. DURING, M.J., NAEGELE, J.R., O'MALLEY, K.L., and GELLER, A.I. (1994). Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
8. EMI, N., FRIEDMANN, T., and YEE, J.-K. (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65, 1202-1207.
9. FAZAKERLEY, J.K., GONZALEZ-SCARANO, F., STRICKLER, J., DIETZSCHOLD, B., KARUSH, F., and NATHANSON, N. (1988). Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology 167, 422-432.
10. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
11. FRAEFEL, C., SONG, S., LIM, F., LANG, P., YU, L., WANG, Y., WILD, P., and GELLER, A. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
12. FRIEDMANN, T. (1994). Gene therapy for neurological disorders. Trends Genet. 10, 210-214.
13. GIRAUD, C., WINOCOUR, E., and BERNS, K.I. (1994). Site-specific integration by adenoassociated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA 91, 10039-10043.
14. GOODMAN. S., XIAO, X., DONAHUE, R.E., MOUTLON, A., MILLER, J., WALSH, C., YOUNG, N.S., SAMULSKI, R.J., and NIENHUIS, A.W. (1994). Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84, 1492-1500.
15. HO, D.Y. (1994). Amplicon-based herpes simplex virus vectors. Methods Cell Biol. 43, 191-210.
16. HUNTER, W., RABKIN, S., and MARTUZA, R. (1995). Brain tumor therapy using genetically engineered replication-competent virus. In Viral Vectors. Eds. M.G. Kaplitt and A.D. Lowey, ed. (Academic Press, New York) pp. 259-274.
17. JOHNSON, P.A., and FRIEDMANN, T. (1994). Replication-defective recombinant herpes simplex virus vectors. Methods Cell Biol. 43, 211-230.
18. JOLLY, D. (1994). Viral vector systems for gene therapy. Cancer Gene Ther. 1, 51-64.
19. JONES, N., and SHENK, T. (1979). Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17, 683-689.
20. KAPLITT, M.G., PFAUS, J.G., KLEOPOULOS, S.P., HANLON, B.A., RABKIN, S.D., and PFAFF, D.W. (1991). Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol. Cell. Neurosci. 2, 320-330.
21. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
22. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration of adeno-associated virus. Proc. Natl. Acad. Sci. USA 87, 2211-2215.
23. KOTIN, R.M., LINDEN, R.M., and BERNS, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
24. KWONG, A.D., and FRENKEL, N. (1995). Biology of herpes simplex virus (HSV) defective viruses and development of the amplicon system. In Viral Vectors. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, New York) pp. 25-42.
25. 5 rep binding site and the consensus ATP-binding motif of the AAV rep68 protein. J. Virol. 69, 6787-6796.
26. LABOW, M.A., HERMONAT, P.L., and BERNS, K.I. (1986). Positive and negative autoregulation of the adeno-associated virus. J. Virol. 60, 251-258.
27. LEIB, D.A., and OLIVO, P.D. (1993). Gene delivery to neurons: Is herpes simplex virus the right tool for the job? BioEssays 15, 547-554.
28. MCKEON, C., and SAMULSKI, R.J. (1996). NIDDK workshop on AAV vectors: Gene transfer into quiescent cells. Hum. Gene Ther. 7, 1615-1619.
29. MIZUKAMI, H., YOUNG, N.S., and BROWN, K.E. (1996). Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 217, 124-130.
30. MONTGOMERY, R.I., LUM, B., and SPEAR, P.G. (1996). Characterization of HVEM, a cellular protein that mediates HSV-1 entry. 21st Herpes Virus Workshop abst. #167.
31. MULLIGAN, R.C. (1993). The basic science of gene therapy. Science 260, 926-932.
32. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
33. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
34. PECHAN, P.A., FOTAKI, M., THOMPSON, R.L., DUNN, R., CHASE, M., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1996). A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors. Hum. Gene Ther. 7, 2003-2013.
35. PONNAZHAGAN, S., WANG, X.S., WOODY, M.J., LUO, F., KANG, L.Y., NALLARI, M.L., MUNSHI, N.C., ZHOU, S.Z., and SRIVASTAVA, A. (1996). Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection. J. Gen. Virol. 77, 1111-1122.
36. PRICE, J., TURNER, D., and CEPKO, C. (1987). Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84, 156-160.
37. RICE, S.A., and KNIPE, D.M. (1990). Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J. Virol. 64, 1704-1715.
38. RUSSELL, D.W., MILLER, A.D., and ALEXANDER, I.E. (1994). Adeno-associated virus vectors preferentially transduce cells in S phase. Proc. Natl. Acad. Sci. USA 91, 8915-8919.
39. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). In Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
40. SAMULSKI, R.J. (1993). Adeno-associated virus: Integration at a specific chromosomal locus. Curr. Opin. Genet. Dev. 3, 74-80.
41. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-3825.
42. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950.
43. SENA-ESTEVES, M., AGHI, M., PECHAN, P., KAYE, E., and BREAKEFIELD, X.O. (1995). Gene delivery to the nervous system using retroviral vectors. In Genetic Manipulation of the Nervous System. D. Latchman, ed. (Academic Press, New York) pp. 149-180.
44. SHELLING, A.N., and SMITH, M.G. (1994). Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 2, 1-5.
45. SMITH, I.L., HARDWICKE, M., and SANDRI-GOLDIN, R.M. (1992). Evidence that the herpes simplex virus immediate protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186, 74-86.
46. SMITH, F., JACOBY, D., and BREAKEFIELD, X.O. (1995). Virus vectors for gene delivery to the nervous system. Rest Neurol. Neurosci. 8, 21-34.
47. SNYDER, R.O., SAMULSKI, R.J., and MUZYCZKA, N. (1990). In vitro resolution of covalently joined AAV chromosome ends. Cell 60, 105-113.
48. SNYDER, R.O., XIAO, X., and SAMULSKI, R.J. (1996). Production of recombinant adeno-associated viral vectors. In Current Protocols in Human Genetics. N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Morton, C. Seidman, J. Scidman, and D. Smith, eds. (John Wiley and Sons, New York) pp. 1-24.
49. UGOLINI, G., KUYERS, H.G., and STRICK, P.L. (1989). Transneuronal transfer of herpes virus from peripheral nerves to cortex and brainstem. Science 243, 89-91.
50. WANG, S., and VOS, J.-M. (1996). A hybrid herpes virus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70, 8422-8430.
51. WARD, P., and BERNS, K.I. (1996). In vitro replication of adeno-associated virua DNA: Enhancement by extracts from adenovirus-infected HeLa cells. J. Virol. 70, 4495-4501.
52. WEITZMAN, M.D., KYOSTIO, S.R.M., KOTIN, R.M., and OWENS, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. USA 91, 5808-5812.